Prostate Cancer

neuroblastoma treatment :: Article Creator NCCN Publishes First-ever Treatment Recommendations Pertaining To Neuroblastoma The National Comprehensive Cancer Network® (NCCN®)-;an alliance of leading cancer centers-;today published its first ever set of treatment recommendations pertaining to neuroblastoma. Neuroblastoma is a type of solid tumor cancer that typically occurs in early childhood, with the majority diagnosed before age five. Neuroblastoma is the most common type of solid tumor (outside of brain tumors) in children, with more than 700 cases diagnosed in the United States every year. Research innovations have led to survival rates that are better than 90% for patients with low- and intermediate-risk neuroblastoma and around 50% for those with high-risk disease. Improving outcomes for patients with high-risk neuroblastoma and reducing long-term treatment effects for all patients remain areas of active research. "Neuroblastoma is a

signs of gum cancer :: Article Creator What To Know About Mouth Cancer And What It Looks Like Mouth cancer can appear on the lips or anywhere in the mouth, including the tissues inside the cheeks, the tongue, and the gums. Mouth cancer may look like red, gray, or white patches of skin, thick growths, or sores that do not heal with time. Mouth cancer is a type of head and neck cancer, and it often comes under the category of oral and oropharyngeal cancer. Oral cancer is cancer that starts in the mouth, or oral cavity, which includes the: lips tongue tongue lining gums inside of the cheeks hard palate (the bony roof of the mouth) floor of the mouth below the tongue Cancer occurs when cancerous cells begin to reproduce and grow out of control. Cells virtually anywhere in the body may become cancerous, and the growth of cancerous cells may spread to other areas of the body. Some signs of precancerous conditions may be indicat

chest cancer symptoms :: Article Creator Lung Cancer Symptoms: What You Should Know Most of the time, lung cancer has no symptoms in its early stages. Your lungs don't have many nerve endings, so a tumor can start to grow there without causing pain. You may not notice the signs until your cancer has begun to spread. When signs of the disease start to appear, they can include: Chronic, hacking, raspy coughing, sometimes with mucus that has blood in it Changes in a cough that you've had for a long time Respiratory infections that keep coming back, including bronchitis or pneumonia Shortness of breath that gets worse Wheezing Lasting chest pain Hoarseness Trouble swallowing Shoulder pain These problems usually happen because of blocked breathing passages or because the cancer has spread farther into the lung, nearby areas, or other parts of the body. Early-stage lung cancer often has few symptoms. When it's cau

prostate 2.4 :: Article Creator Black Men With Advanced Prostate Cancer Are Less Likely To Get The Most Effective Therapies About 1 in 8 men will be diagnosed with prostate cancer in his lifetime. [1] Although prostate cancer is the second leading cause of cancer death in men, behind only lung cancer, the average patient with prostate cancer will not die from the disease. [1] Recent advances in treatment, notably the new hormone therapy agents enzalutamide (Xtandi), apalutamide (Erleada), and darolutamide (Nubeqa), have extended the lives of people with advanced prostate cancer. [2] But for certain patients, the statistics are not quite as rosy. Black men are 1.5 times as likely as white men to be diagnosed with prostate cancer in the United States, and advanced prostate cancer is 2.4 times more lethal in Black men than in white men. [3] Could differences in the use of these novel hormonal therapies play a role in this discrepancy in morta

chronic myeloid leukemia prognosis :: Article Creator Worse Overall Survival Seen For Adults With Leukemia With CNS Involvement For adults with acute myeloid leukemia (AML), those with central nervous system (CNS) involvement have worse overall survival, according to a review published in the February issue of Leukemia Research. Hannah Goulart, M.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues conducted a systematic review and meta-analysis to characterize survival outcomes in patients with AML with CNS involvement. Survival outcomes and response rates were examined from clinical studies of patients with AML stratified by CNS involvement. The meta-analysis included 12 studies. The researchers found that overall survival was worse for patients with CNS involvement versus those without CNS involvement. In three studies examining complete remission, there was no significant difference observed for patients